Authors: Bebernitz, GR Dain, JG Deems, RO Otero, DA Simpson, WR Strohschein, RJ

Citation: Gr. Bebernitz et al., Reduction in glucose levels in STZ diabetic rats by 4-(2,2-dimethyl-1-oxopropyl)benzoic acid: A prodrug approach for targeting the liver, J MED CHEM, 44(4), 2001, pp. 512-523

Authors: Bebernitz, GR Argentieri, G Battle, B Brennan, C Balkan, B Burkey, BF Eckhardt, M Gao, JP Kapa, P Strohschein, RJ Schuster, HF Wilson, M Xu, DD

Citation: Gr. Bebernitz et al., The effect of 1,3-diaryl-[1H]-pyrazole-4-acetamides on glucose utilizationin ob/ob mice, J MED CHEM, 44(16), 2001, pp. 2601-2611

Authors: Bebernitz, GR Aicher, TD Stanton, JL Gao, JP Shetty, SS Knorr, DC Strohschein, RJ Tan, J Brand, LJ Liu, C Wang, WH Vinluan, CC Kaplan, EL Dragland, CJ DelGrande, D Islam, A Lozito, RJ Liu, XL Maniara, WM Mann, WR

Citation: Gr. Bebernitz et al., Anilides of (R)-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase, J MED CHEM, 43(11), 2000, pp. 2248-2257

Authors: Aicher, TD Anderson, RC Bebernitz, GR Coppola, GM Jewell, CF Knorr, DC Liu, C Sperbeck, DM Brand, LJ Strohschein, RJ Gao, JP Vinluan, CC Shetty, SS Dragland, C Kaplan, EL DelGrande, D Islam, A Liu, XL Lozito, RJ Maniara, WM Walter, RE Mann, WR

Citation: Td. Aicher et al., (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinase, J MED CHEM, 42(15), 1999, pp. 2741-2746

Authors: Aicher, TD Bebernitz, GR Bell, PA Brand, LJ Dain, JG Deems, R Fillers, WS Foley, JE Knorr, DC Nadelson, J Otero, DA Simpson, R Strohschein, RJ Young, DA

Citation: Td. Aicher et al., Hypoglycemic prodrugs of 4-(2,2-dimethyl-1-oxopropyl)benzoic acid, J MED CHEM, 42(1), 1999, pp. 153-163